FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116571008: Betamethasone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177223017 Betamethasone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
679767016 Betamethasone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
177223017 Betamethasone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
177223017 Betamethasone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
679767016 Betamethasone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
679767016 Betamethasone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
53031000195112 betametasone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
67901000195115 Betamethason de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
860761000172111 bétaméthasone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
860761000172111 bétaméthasone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
53031000195112 betametasone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
67901000195115 Betamethason de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betamethasone Is a Synthetic glucocorticoid, fluorinated false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone Is a Pregnane (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone Has disposition Immunomodulator (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone Is a Immunomodulator true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone Is a Fluorinated corticosteroid true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone Is a Glucocorticoid (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone Has disposition Hormone (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Betamethasone acetate Is a False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate Is a False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone benzoate Is a False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing clobetasol (medicinal product) Is a False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone dipropionate Is a False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone adverse reaction Causative agent (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Augmented betamethasone dipropionate Is a False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Clobetasol propionate Is a False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone ester Is a False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone allergy Causative agent (attribute) False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing betamethasone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Intramuscular injection of betamethasone Direct substance False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone 500micrograms soluble tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone 500 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
bétaméthasone 4 mg/mL, ampoule de 1 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone 0.1% scalp application (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone 0.1% cream (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone 0.1% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone 0.1% lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone+salicylic acid 0.05/3% scalp application The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone 0.05% cream (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone + antimicrobials The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone+clotrimazole 0.05/1% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing betamethasone and clioquinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone- and clotrimazole-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing betamethasone and fusidic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing betamethasone and salicylic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Topical betamethasone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing betamethasone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Parenteral betamethasone (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely betamethasone 600 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone 0.6mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone dipropionate + clotrimazole 0.64mg/10mg cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone dipropionate + clotrimazole ns/10mg lotion (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone+calcipotriol (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone valerate Is a False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phospha 3mg/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate 4mg/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone dipropionate + clotrimazole ns/10mg lotion (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone- and neomycin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing betamethasone in ophthalmic dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Intramuscular injection of betamethasone Direct substance True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Measurement of betamethasone (procedure) Component True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone allergy Causative agent (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone 500 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone 500 microgram oral tablet Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely betamethasone 600 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely betamethasone 600 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone dipropionate Is modification of (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone valerate Is modification of (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone benzoate Is modification of (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone acetate Is modification of (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate Is modification of (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone 600 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone 500 microgram oral tablet Has precise active ingredient True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous cream (clinical drug) Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone valerate) 1 mg/g cutaneous cream Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) Has basis of strength substance (attribute) False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has basis of strength substance (attribute) False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection ampule Has basis of strength substance (attribute) False Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has basis of strength substance (attribute) True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing betamethasone in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing betamethasone and salicylic acid in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing betamethasone and fusidic acid in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone- and neomycin-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone- and clotrimazole-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone- and neomycin-containing product in ocular dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone and clotrimazole only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only betamethasone and fusidic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone and calcipotriol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only betamethasone and clioquinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only betamethasone and neomycin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Betamethasone Inferred relationship Existential restriction modifier (core metadata concept) 1

Page 1 of 2 End


This concept is not in any reference sets

Back to Start